tradingkey.logo
tradingkey.logo
Search

Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial

ReutersJun 24, 2025 11:33 AM
facebooktwitterlinkedin

- Nektar Therapeutics NKTR.O said on Tuesday its experimental eczema drug had met the main goals of a mid-stage study.

Shares of the company were halted in premarket trading.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI